Antibody Fc mutants with ablated effector functions
US9637549B2 · kind B2 · utility
6Cited by
6References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 15, 2015 |
| Grant date | May 2, 2017 |
| Priority date | — |
| Expiry date | Jan 15, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Antibody and other Fc-containing molecules with variations in the Fc region reduce binding to Fc gamma receptors and resulting activity and can be used in the treatment of various diseases and disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.